DocGo Inc. (NASDAQ:DCGO) Receives Average Rating of “Buy” from Analysts

DocGo Inc. (NASDAQ:DCGO) has been assigned an average rating of “Buy” from the five analysts that are presently covering the company, Marketbeat Ratings reports. Five research analysts have rated the stock with a buy recommendation. The average 1-year target price among analysts that have covered the stock in the last year is $6.10.

Several brokerages have recently weighed in on DCGO. Needham & Company LLC reiterated a “buy” rating and issued a $7.00 price target on shares of DocGo in a report on Thursday, August 8th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $5.00 target price on shares of DocGo in a research note on Friday, September 20th.

DocGo Stock Down 2.4 %

DCGO opened at $3.20 on Friday. The company has a market capitalization of $325.01 million, a PE ratio of 16.15, a price-to-earnings-growth ratio of 2.73 and a beta of 0.91. The firm has a 50-day simple moving average of $3.46 and a two-hundred day simple moving average of $3.34. DocGo has a 52 week low of $2.75 and a 52 week high of $6.90.

DocGo (NASDAQ:DCGO) last released its quarterly earnings results on Wednesday, August 7th. The company reported $0.06 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.01). The business had revenue of $164.95 million for the quarter, compared to analysts’ expectations of $166.61 million. DocGo had a net margin of 3.97% and a return on equity of 8.90%. As a group, sell-side analysts expect that DocGo will post 0.23 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of DCGO. Deerfield Management Company L.P. Series C grew its position in shares of DocGo by 41.0% in the second quarter. Deerfield Management Company L.P. Series C now owns 7,195,956 shares of the company’s stock valued at $22,236,000 after purchasing an additional 2,091,569 shares in the last quarter. Vanguard Group Inc. grew its holdings in DocGo by 1.1% in the 1st quarter. Vanguard Group Inc. now owns 4,857,416 shares of the company’s stock valued at $19,624,000 after buying an additional 52,571 shares in the last quarter. P.A.W. Capital Corp increased its stake in shares of DocGo by 6.7% in the 2nd quarter. P.A.W. Capital Corp now owns 1,600,000 shares of the company’s stock worth $4,944,000 after acquiring an additional 100,000 shares during the last quarter. Isthmus Partners LLC raised its holdings in shares of DocGo by 32.4% during the 2nd quarter. Isthmus Partners LLC now owns 799,296 shares of the company’s stock worth $25,000 after acquiring an additional 195,428 shares during the period. Finally, Marshall Wace LLP boosted its position in shares of DocGo by 212.4% during the 2nd quarter. Marshall Wace LLP now owns 505,514 shares of the company’s stock valued at $1,562,000 after acquiring an additional 343,692 shares during the last quarter. 56.44% of the stock is owned by hedge funds and other institutional investors.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.